Editorial method
Keep the exact product attached.
Our method distinguishes ingredient descriptions, approved-product labeling, proposed uses and the service arrangements advertised around a medicine.
Read the record before the claim
We identify the named medicine, its form, its labeled indication and the kind of source being cited. A shared ingredient does not transfer approval, complete ingredients or all clinical evidence from one finished product to another.
Do not turn a strength into an instruction
An advertised strength or pharmacy quantity may help identify a product or price unit. We do not use those numbers to recommend a dose, conversion, substitution, missed-dose response, taper or washout schedule. A clinician must make treatment decisions for the actual person.
Preserve the safety context
Interaction information belongs in a full medicine review. We retain labeled precautions and evidence limitations rather than presenting a short list as a self-screening tool. A proposed benefit does not eliminate questions about other prescriptions, symptoms or prescriber coordination.
Keep dates clear
An online record’s update date and the revision date inside its prescribing information can differ. We record the document being used and the date it was checked. A current page is not proof of a newly revised label or a completed treatment-specific enrollment flow.
Separate the offer from the result
Provider and pharmacy sources can support statements about advertised access, prices and service descriptions. They do not establish a patient outcome. Unknown product identity, costs or follow-up arrangements remain explicit questions rather than invented details.
Explain the commercial order
CoreAge receives first commercial placement through this publication’s promotional relationship. That placement does not determine an efficacy score or imply competitors provide inferior care. Editorial source checking is not a clinician endorsement or an independent treatment trial.